Sarah D de Ferranti Selected Research

Sarah D de Ferranti Research Topics

Disease

12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2011
9	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2021 - 05/2011
7	Dyslipidemias (Dyslipidemia) 11/2020 - 01/2016
6	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021 - 10/2017
6	Hypertension (High Blood Pressure) 01/2020 - 07/2006
5	Obesity 01/2020 - 06/2015
4	Hypercholesterolemia 01/2022 - 04/2016
4	Aneurysm (Aneurysms) 10/2020 - 10/2017
4	Atherosclerosis 09/2015 - 01/2007
3	Myocarditis (Carditis) 10/2022 - 12/2021
2	Heart Diseases (Heart Disease) 10/2022 - 11/2007
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 11/2019
2	Fever (Fevers) 12/2021 - 01/2019
2	Hemorrhage 10/2020 - 10/2017
2	Chronic Disease (Chronic Diseases) 01/2020 - 11/2016
2	Aortic Coarctation 01/2019 - 09/2018
2	Inflammation (Inflammations) 01/2019 - 01/2016
2	Coronary Disease (Coronary Heart Disease) 06/2011 - 05/2011
2	Overweight 04/2011 - 08/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2006 - 10/2004
1	Infections 10/2022
1	COVID-19 07/2022
1	Myalgia 12/2021
1	Chest Pain (Chest Pains) 12/2021
1	Ischemic Stroke 12/2021
1	Headache (Headaches) 12/2021
1	Hyperferritinemia 11/2020
1	Cytopenia 11/2020
1	Lymphopenia (Lymphocytopenia) 11/2020
1	Thrombocytopenia (Thrombopenia) 11/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2020
1	Thrombosis (Thrombus) 10/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2020
1	Homozygous Familial Hypercholesterolemia 01/2020
1	Coronary Aneurysm (Aneurysm, Coronary) 01/2019
1	Hypertriglyceridemia 01/2019
1	Congenital Heart Defects (Congenital Heart Defect) 12/2018
1	Diabetes Mellitus 01/2018
1	Muscular Diseases (Myopathy) 01/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2016
1	Body Weight (Weight, Body) 04/2016
1	Lipodystrophy 04/2016

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 01/2022 - 05/2011
11	CholesterolIBA 01/2022 - 08/2010
8	LDL CholesterolIBA 01/2022 - 09/2015
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2016
6	oxidized low density lipoproteinIBA 12/2021 - 01/2015
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 12/2018
4	Triglycerides (Triacylglycerol)IBA 11/2019 - 04/2011
3	VaccinesIBA 10/2022 - 12/2021
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2007
3	Proprotein Convertase 9IBA 12/2017 - 04/2016
2	COVID-19 VaccinesIBA 07/2022 - 12/2021
2	GadoliniumIBA 07/2022 - 12/2021
2	BNT162 VaccineIBA 07/2022 - 12/2021
2	Insulin (Novolin)FDA Link 01/2022 - 01/2016
2	Warfarin (Coumadin)FDA LinkGeneric 10/2020 - 10/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 10/2017
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2016 - 09/2015
2	C-Reactive ProteinIBA 01/2007 - 07/2006
1	mRNA VaccinesIBA 07/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Insulin ReceptorIBA 01/2022
1	Simvastatin (Zocor)FDA LinkGeneric 01/2022
1	Ezetimibe (Zetia)FDA Link 01/2022
1	Steroid 12-alpha-Hydroxylase (CYP8B1)IBA 01/2022
1	Messenger RNA (mRNA)IBA 12/2021
1	fibrin fragment D (D-dimer)IBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	CytokinesIBA 11/2020
1	Interleukin-10 (Interleukin 10)IBA 11/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2020
1	evolocumabIBA 10/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	campesterolIBA 11/2019
1	gamma-sitosterol (beta-sitosterol)IBA 11/2019
1	lathosterolIBA 11/2019
1	Hemoglobins (Hemoglobin)IBA 11/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 12/2018
1	Coenzyme A (CoA)IBA 09/2018
1	ElementsIBA 11/2016
1	PCSK9 InhibitorsIBA 07/2016
1	A 7 (A-7)IBA 07/2016
1	Caspase 8 (Caspase-8)IBA 07/2016
1	LeptinIBA 04/2016
1	SmokeIBA 04/2015

Therapy/Procedure

6	Therapeutics 01/2021 - 11/2016
2	Stents 01/2019 - 09/2018
2	Drug Therapy (Chemotherapy) 09/2015 - 01/2013
1	Glycemic Control 01/2022
1	Blood Component Removal (Apheresis) 01/2020
1	Transitional Care 01/2020
1	Length of Stay 01/2019
1	Aftercare (After-Treatment) 12/2018